AM

Abishek Meenambika Sindhukumar

Active Director Director DIN 10437800
DIN 10437800 First appointment Jan 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Abishek Meenambika Sindhukumar

Data last updated:

Abishek Meenambika Sindhukumar is a Director at Mark R&D Private Limited (since 2024).

DIN 10437800
Primary Designation Director
First Appointment 08 Jan 2024
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Mark R&D Private Limited U62099KA2023PTC172589
Director08 Jan 20242023Active

Board colleagues of Abishek Meenambika Sindhukumar

NameDINCompanyDesignation
Sreejith08192883Mark R&D Private LimitedDirector
Vinoth Viswanathapillai Vijayarani08254185Mark R&D Private LimitedManaging Director

Directorship timeline

Open interactive timeline →
Mark R&D Private Limited
Premium access

Shareholding and investment profile for Abishek Meenambika Sindhukumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Abishek Meenambika Sindhukumar

Abishek Meenambika Sindhukumar currently holds 1 directorship: Mark R&D Private Limited (Director, since 08 Jan 2024).

Abishek Meenambika Sindhukumar was first appointed on 08 Jan 2024 as Director at Mark R&D Private Limited.

The current boards of Abishek Meenambika Sindhukumar's companies include Sreejith (Mark R&D Private Limited), Vinoth Viswanathapillai Vijayarani (Mark R&D Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available